Article
Methylation, Gene Expression, and Risk Genotypes at the TERT-CLPTM1L Locus in Cervical Cancer.
Molecular carcinogenesis - 1 Jan 2025
Ramachandran Dhanya, Mao Qianqian, Liao Dandan, Kamal Maud, Schürmann Peter, Eisenblätter Rieke, Geffers Robert, Balint Balazs, Lecompte Lolita, Servant Nicolas, Chérif Linda Larbi, Lamy Constance, Baulande Sylvain, Legoix Patricia, Le Tourneau Christophe, Latouche Aurélien, Hillemanns Peter, Scholl Suzy, Dörk Thilo
Abstract excerpt
The reverse transcriptase subunit of telomerase, TERT, is frequently activated in high-grade dysplasia and invasive cancers of the uterine cervix. Telomerase activation through hypomethylation of the TERT promoter holds promise as a biomarker for cervical cancer progression, however, specific CpG sites involved in cervical cancer risk remain to be fully defined. A recent genome-wide association study on cervical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
